(Q37978530)

26 August 2017

0 references

The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review (English)

1 reference

26 August 2017

0 references

0 references

Jin-Tao Qu

1

1 reference

26 August 2017

Mei Wang

2

1 reference

26 August 2017

Hai-Long He

3

1 reference

26 August 2017

Yu Tang

4

1 reference

26 August 2017

Xiao-Jian Ye

5

1 reference

26 August 2017

language of work or name

1 reference

25 January 2012

1 reference

Journal of Cancer Research and Clinical Oncology

26 August 2017

published in

1 reference

26 August 2017

volume

138

1 reference

26 August 2017

issue

5

1 reference

26 August 2017

page(s)

819-825

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-012-1149-7

26 August 2017

exact match

0 references

cites work

Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

The level of vascular endothelial growth factor as a predictor of a poor prognosis in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

Survival in high-grade osteosarcoma: improvement over 21 years at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1149-7

Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis

21 January 2018

1 reference

12 December 2020

CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis

1 reference

12 December 2020

Expression and significance of TGF-beta isoform and VEGF in osteosarcoma

1 reference

12 December 2020

Intratumor microvessel density as a prognostic factor in cancer

1 reference

12 December 2020

Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma

1 reference

12 December 2020

Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma

1 reference

12 December 2020

Is determination of angiogenic activity in human tumours clinically useful?

1 reference

12 December 2020

Vascular endothelial growth factor: biology and therapeutic applications

1 reference

12 December 2020

Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?

1 reference

12 December 2020

Vascular endothelial growth factor expression in osteosarcoma

1 reference

12 December 2020

Expression of molecular markers in the tumor and survival prognosis in osteosarcoma

1 reference

12 December 2020

10.1007/S00432-012-1149-7

Identifiers

DOI

1 reference

26 August 2017

1 reference